Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 30:2018:8538573.
doi: 10.1155/2018/8538573. eCollection 2018.

Ocular Manifestations of Alzheimer's and Other Neurodegenerative Diseases: The Prospect of the Eye as a Tool for the Early Diagnosis of Alzheimer's Disease

Pade Colligris  1   2 , Maria Jesus Perez de Lara  2   3 , Basilio Colligris  2   3 , Jesus Pintor  2   3
Affiliations
Review

Ocular Manifestations of Alzheimer's and Other Neurodegenerative Diseases: The Prospect of the Eye as a Tool for the Early Diagnosis of Alzheimer's Disease

Pade Colligris et al. J Ophthalmol. .

Abstract

Dementia, including Alzheimer's disease (AD), is a major disorder, leading to several ocular manifestations amongst the elderly population. These visual disorders may be due to retinal nerve degenerative changes, including nerve fibre layer thinning, degeneration of retinal ganglion cells, and changes to vascular parameters. There is no cure for Alzheimer's, but medicines can slow down the development of many of the classic symptoms, such as loss of memory and communication skills, mood swings, and depression. The disease diagnosis is difficult, and it is only possible through PET scans of the brain, detecting evidence of the accumulation of amyloid and tau. PET is expensive and invasive, requiring the injection of radioactive tracers, which bind with these proteins and glow during scanning. Recently, scientists developed promising eye-scan techniques that may detect Alzheimer's disease at its earliest stage, before major symptoms appear, leading to improved management of the disease symptoms. In this review, we are discussing the visual abnormalities of Alzheimer's and other neurodegenerative diseases, focused on ocular functional-visual-structural biomarkers, retinal pathology, and potential novel diagnostic tools.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alzheimer’s Association. 2013 Alzheimer’s disease facts and figures. Alzheimer’s and Dementia. 2013;9(2):208–245. doi: 10.1016/j.jalz.2013.02.003. - DOI - PubMed
    1. Querfurth H. W., LaFerla F. M. Alzheimer’s disease. New England Journal of Medicine. 2010;362(4):329–344. doi: 10.1056/nejmra0909142. - DOI - PubMed
    1. Kivipelto M., Helkala E. L., Laakso M. P., et al. Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study. BMJ. 2001;322(7300):1447–1451. doi: 10.1136/bmj.322.7300.1447. - DOI - PMC - PubMed
    1. Luchsinger J. A., Gustafson D. R. Adiposity, type 2 diabetes, and Alzheimer’s disease. Journal of Alzheimers Disease. 2009;16(4):693–704. doi: 10.3233/jad-2009-1022. - DOI - PMC - PubMed
    1. Ahtiluoto S., Polvikoski T., Peltonen M., et al. Diabetes, Alzheimer’s disease, and vascular dementia a population-based neuropathologic study. Neurology. 2010;75(13):1195–1202. doi: 10.1212/wnl.0b013e3181f4d7f8. - DOI - PubMed